OA
OLUKOTUN ADEOYE Y
Director
OFFICERM
Insider track record
ExecutiveAcross 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by OLUKOTUN ADEOYE Y, Director. Officer active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 17 filings have been recorded. Split: 0 buy · 11 sells. Total volume traded: €1.6m. History available since 13 September 2021. The latest transaction was disclosed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations17 total
3,090 shares@ US$66.7021.8% of flowCommon StockSEC:0001242615-25-000006
3,090 shares@ US$66.700.0016% mcap21.8% of flowCommon StockSEC:0001242615-25-000006:0
6,083 shares@ US$68.0415.0% of flowCommon StockSEC:0001242615-25-000006:1
827 shares@ US$68.482.1% of flowCommon StockSEC:0001242615-25-000006:2
0.812 shares@ US$1.91100.0% of flowCommon Stock, par value $0.001SEC:0001839882-25-012471:0
959 shares@ US$21.000.8% of flowCommon StockSEC:0001628280-25-002716:0
2,850 shares@ US$20.002.3% of flowCommon StockSEC:0001628280-24-052592:0
16,733 shares@ US$22.9915.6% of flowCommon StockSEC:0001628280-24-052273:0
14,987 shares@ US$25.4114.8% of flowCommon StockSEC:0001628280-23-041966:0
11,350 shares@ US$32.6514.9% of flowCommon StockSEC:0001209191-23-016446:0
7,867 shares0Common StockSEC:0001209191-23-003071:0
6,400 shares0Common StockSEC:0001209191-22-002593
6,400 shares0Common StockSEC:0001209191-22-002593:0
1,890 shares@ US$64.260.0010% mcap26.4% of flowCommon StockSEC:0001209191-22-001328
1,890 shares@ US$64.260.0010% mcap13.2% of flowCommon StockSEC:0001209191-22-001328:0
2,250 shares@ US$63.760.0011% mcap15.0% of flowCommon StockSEC:0001209191-21-055966:0
2,250 shares@ US$63.760.0011% mcap30.1% of flowCommon StockSEC:0001209191-21-055966
About OLUKOTUN ADEOYE Y
OLUKOTUN ADEOYE Y serves as a Director at ARROWHEAD PHARMACEUTICALS, INC. In this role, he contributes to the governance and strategic direction of the company. His experience in the biopharmaceutical sector allows him to provide valuable insights on growth and innovation opportunities. Adeoye plays a key role in overseeing operations and evaluating company performance.